Hemagen Diagnostics

HMGN · OTC

$0.0002+$0.0002 (+0.00%)TodayMarket closed · Aug 26, 3:36 PM ET

No price history for this range.

About HMGN

Hemagen Diagnostics, Inc. is a biotechnology company. The company is headquartered in Columbia, Maryland and currently employs 15 full-time employees. The firm is primarily focused on Veterinary Clinical Diagnostics. The company is also focused on VIRGO, its Human Clinical Diagnostic line of autoimmune and infectious disease products. The firm develops, manufactures and markets a range of test kits used to aid in the diagnosis of certain autoimmune and infectious diseases. The Company’s autoimmune product portfolio includes Hemagen DNA Kit, Hemagen Rheumatoid Factor Kit, VIRGO AMA IgG, VIRGO ANA/Hep-2 IgG, VIRGO Anti-nDNA IgG, VIRGO cANCA (PR-3) Kit, VIRGO dsDNA Kit, VIRGO ENA Screen 6 Kit, VIRGO ENA Screening, VIRGO ENA Series, VIRGO pANCA myeloperoxidase (MPO) Kit and VIRGO Rheumatoid Factor Kit. The company offers various products for infectious disease, which includes VIRGO C. trach IgG, VIRGO CMV IgG and VIRGO epstein-barr virus (EBV)- viral capsid antigen (VCA) IgG. Its products are used in laboratories, hospitals and blood banks around the world.

Employees: 15
Headquarters: Columbia, Maryland
Listed: Feb 4, 1993
Sector: Health Care
Industry: Health Care Equipment & Supplies
Website: hemagen.com

Leadership

Hemagen Diagnostics executives
Name	Title	Since	Age
William Hales	—	1999	50
M. Robert Campbell	—	—	43
Catherine Davidson	—	—	47
Alan Cohen	—	—	86
Edward Lutz	—	—	66

Similar companies

Companies in the same industry as Hemagen Diagnostics

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.